FAMILIAL HYPERCHOLESTEROLEMIA
Clinical trials for FAMILIAL HYPERCHOLESTEROLEMIA explained in plain language.
Never miss a new study
Get alerted when new FAMILIAL HYPERCHOLESTEROLEMIA trials appear
Sign up with your email to follow new studies for FAMILIAL HYPERCHOLESTEROLEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Which contact method best warns families of hidden cholesterol danger?
Knowledge-focused Not yet recruitingThis study compares two approaches to notify relatives of people diagnosed with familial hypercholesterolemia (FH), a genetic condition causing very high cholesterol. One method lets patients share information themselves; the other has the study team contact relatives directly. R…
Matched conditions: FAMILIAL HYPERCHOLESTEROLEMIA
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Are cholesterol patients getting the right care? new study aims to find out
Knowledge-focused Not yet recruitingThis study will follow about 2,500 adults in Italy who have high cholesterol and are at high risk for heart problems. Researchers want to see if their current treatments match official guidelines and how well their cholesterol is controlled over one year. The goal is to find gaps…
Matched conditions: FAMILIAL HYPERCHOLESTEROLEMIA
Sponsor: Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Italian study to track Real-World use of Next-Gen cholesterol drugs
Knowledge-focused Not yet recruitingThis study will look at how consistently nearly 6,000 adults in Italy take three newer cholesterol-lowering drugs (inclisiran, evolocumab, and alirocumab) over the long term. Researchers will analyze prescription records to measure adherence and persistence in everyday medical pr…
Matched conditions: FAMILIAL HYPERCHOLESTEROLEMIA
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Cholesterol drug showdown: which one do patients actually take?
Knowledge-focused Not yet recruitingThis study will look at medical records from 3,600 people in Japan to see how well they follow their prescribed cholesterol-lowering medication. It compares two drugs, inclisiran and evolocumab, over 12 months. The goal is to understand real-world adherence, not to test new treat…
Matched conditions: FAMILIAL HYPERCHOLESTEROLEMIA
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC